By Ernie Mundell HealthDay Reporter
Potent new antivirals may hold steady against Omicron. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the mutation-heavy variant, because they interfere with the ability of the coronavirus to replicate itself rather than its ability to infect human cells, experts say. Read more
Hope from an mRNA-based vaccine against HIV. In animal studies, the same mRNA technology that brought the world COVID vaccines appears to help combat the virus that causes AIDS. Read more
World unprepared for the next pandemic. Despite the havoc and suffering meted out by SARS-CoV-2, nations around the globe still aren’t prepared to prevent or deal with another pandemic because many aren’t taking the necessary measures, according to this year’s Global Health Security (GHS) index. Read more
Beware ‘wellness’ vapes. Despite claims that certain e-cigarette products may ease health problems, there’s no proof that they do — and they may even cause health issues, the U.S. Food and Drug Administration warns. Read more
© 2021 HealthDay. All rights reserved.
Posted December 2021
Read this next
More News Resources
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.